title: RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.
authors.affiliation: Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Texas Oncology, P.A., US Oncology, Dallas, TX, USA. joyce.oshaughnessy@usoncology.com
authors.forename: Joyce A
authors.initials: JA
authors.lastname: O'Shaughnessy
authors.forename: Adam M
authors.initials: AM
authors.lastname: Brufsky